Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.44 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14278328 | 0.91 | ALDH1A1 (0.64) | ALDH1A1KMT2AMAPTMAPK1POLB | |
| SCHEMBL17257666 | 0.85 | L3MBTL1 (0.49) | ALDH1A1KMT2AMAPTMAPK1POLB | |
| SCHEMBL11881152 | 0.85 | ALDH1A1 (0.48) | ALDH1A1KMT2AMAPTMAPK1POLB | |
| SCHEMBL8189831 | 0.84 | RAB9A (0.55) | ALDH1A1KMT2APOLBSMN1; SMN2NPSR1 | |
| SCHEMBL212911 | 0.83 | MAPT (0.60) | ALDH1A1MAPTMAPK1POLBSMN1; SMN2 | |
| SCHEMBL11963959 | 0.83 | MAPT (0.60) | ALDH1A1MAPTMAPK1POLBSMN1; SMN2 | |
| SCHEMBL2045675 | 0.83 | CYP2C19 (0.48) | ALDH1A1MAPTMAPK1POLBSMN1; SMN2 | |
| SCHEMBL2045676 | 0.83 | CYP2C19 (0.48) | ALDH1A1MAPTMAPK1POLBSMN1; SMN2 | |
| SCHEMBL14667470 | 0.83 | MAPT (0.60) | ALDH1A1MAPTMAPK1POLBSMN1; SMN2 | |
| SCHEMBL5731740 | 0.82 | ALDH1A1 (0.42) | ALDH1A1KMT2AMAPTMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114850480-A | Preparation method of high-conductivity flake silver powder for touch screen silver paste | 中船重工黄冈贵金属有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-108484480-B | Diphenyl methyl ketoxime acetate containing dicarbazole as photoinitiator, preparation method and application thereof | 三峡大学 | 2021-02-02 | — | — | CN | claimed |
| CN-108484480-A | A kind of diphenyl-ketoxime acetic acid esters of the photoinitiator containing double carbazoles, preparation method and applications | 三峡大学 | 2018-09-04 | — | — | CN | claimed |
| CN-108467390-A | A kind of thiophene diformazan ketoxime acetic acid esters of the photoinitiator containing double carbazoles, preparation method and applications | 三峡大学 | 2018-08-31 | — | — | CN | claimed |
| US-20120077941-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2012-03-29 | — | — | US | claimed |
| US-8088868-B2 | oximation of cojugated homopolymers formed by addtion polymerization of conjugated diene monomer in the presence lanthanide copmpounds as polymerization catalysts; polymers used in the manufacture of tires having reduced hysteresis | BRIDGESTONE CORPORATION (JP) | 2012-01-03 | — | — | US | claimed |
| US-20080146745-A1 | POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS | BRIDGESTONE CORPORATION (JP) | 2008-06-19 | — | — | US | claimed |
| US-20250230165-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | ARTIOS PHARMA LIMITED (GB) | 2025-07-17 | — | — | US | disclosed |
| CN-119525482-A | Micron-sized flake silver powder for HJT solar cells and preparation method thereof | 中船黄冈贵金属有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-114850480-B | Preparation method of high-conductivity flake silver powder for touch screen silver paste | 中船黄冈贵金属有限公司 | 2023-09-19 | — | — | CN | disclosed |
| WO-2023107597-A2 | BICYCLIC HETEROAROMATIC AMIDE COMPOUNDS AND USES THEREOF | Kineta, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
| CN-115968113-A | Method for manufacturing structure with conductive pattern, kit and system | 旭化成株式会社 | 2023-04-14 | — | — | CN | disclosed |
| CN-109651289-B | 3-thiazoline compound and synthetic method and application thereof | 五邑大学 | 2022-08-09 | — | — | CN | disclosed |
| EP-1615926-A1 | (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF | Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004094426-A1 | (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF | USTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKÉ REPUBLIKY (CZ) | 2004-11-04 | — | — | WO | disclosed |
| US-5854232-A | Acyclic anc cyclic amides as neurotransmitter release enhancers | PFIZER INC. (US) | 1998-12-29 | — | — | US | disclosed |
| EP-0321618-B1 | PHOTOSENSITIVE HARDENABLE COMPOSITIONS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-17 | — | — | EP | disclosed |
| US-4885229-A | CONTAINING ACRYLATED ESTERS | 501 DAICEL CHEMICAL INDUSTRIES LTD. (JP) | 1989-12-05 | — | — | US | disclosed |
| EP-0321618-A1 | Photosensitive hardenable compositions | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1989-06-28 | — | — | EP | disclosed |
| US-4590145-A | Photopolymerization initiator comprised of thioxanthones and oxime esters | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1986-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230165-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | NQO1, VHL, SDHA | ALDH1A1 174/4885KMT2A 994/4885MAPT 3497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.